01-01-1970 12:00 AM | Source: ICICI Direct
Buy Tata Consumer Products Ltd For Target Rs.910 - ICICI Direct
News By Tags | #872 #5958 #3961 #1302 #6171

Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel

https://t.me/InvestmentGuruIndiacom

Download Telegram App before Joining the Channel

Margin trajectory to move upwards...

About the stock: Tata Consumer Products (TCPL) is one of the major FMCG companies present in tea, coffee & other beverages in India, UK, US, Canada and some other geographies. In India, it also has salt, pulses, spices & other food products. Its subsidiary NourishCo is present in packaged water & other beverages. The company is in a JV with Starbucks, which has 233 stores in India.

* The company has 1500 distribution directly reaching to 1.1 million outlets in India. This will be increased to 1.3 million outlets by March 2022

* TCPL is also increasing its rural presence by increasing rural distributors to 5000 by March 2022

 

Q2FY22 Results: TCPL posted healthy numbers with 9.1% revenue growth

* Sales were up 9.1% YoY (11% like to like) aided by foods business growth

* EBITDA was at | 413.3 crore, up 3.4% YoY, with margins at 13.6%

* Consequent PAT was at | 285.8 crore (up 4.6% YoY)

 

What should investors do? TCPL’s share price has moved up 5.6x in the last five years (from | 140 in October 2016 to | 789 in October 2021).

* We slightly change our numbers downwards on the back of slower growth in the India & International beverage business

* We continue to maintain our BUY rating on the stock

Target Price and Valuation: We value the stock at | 910 on ascribing 56x FY24 earnings multiple

 

Key triggers for future price performance:

* TCPL is likely to witness strong margin improvement with a dip in tea procurement prices

* Strong innovation & premiumisation strategy in salt, tea, Sampaan & Soulful in India market expected to drive sales & margins

* With the increase in mobility, Starbucks is expected to witness a swift recovery. Store expansion is expected to drive growth

 

Alternate Stock Idea: We also like Zydus Wellness in our FMCG coverage.

* It is growing at a steady pace in nascent categories with strong presence in health, nutrition space & margin expansion possibilities

* Trading at a significant discount to FMCG peers. BUY with a TP of | 2,800

 

 

To Read Complete Report & Disclaimer Click Here

 

 

https://secure.icicidirect.com/Content/StaticData/Disclaimer.html

 

Above views are of the author and not of the website kindly read disclaimer